| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. | Lancet | 2002 | 3.95 |
| 2 | Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis. | Antimicrob Agents Chemother | 2002 | 2.03 |
| 3 | A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. | Clin Infect Dis | 2003 | 1.16 |
| 4 | Building clinical trials capacity for tuberculosis drugs in high-burden countries. | PLoS Med | 2007 | 1.04 |
| 5 | The association between symptoms and microbiologically defined response to tuberculosis treatment. | Ann Am Thorac Soc | 2013 | 0.92 |
| 6 | Prenatal HIV-antibody testing and the meaning of consent. | AIDS Public Policy J | 1994 | 0.89 |